| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |